According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is $0.70. In 2022 the company made an earnings per share (EPS) of $0.67 a decrease over its 2021 EPS that were of $1.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.70 | 3.79% |
2022 | $0.67 | -32.67% |
2021 | $1.00 | -16.9% |
2020 | $1.20 | 2.54% |
2019 | $1.17 | 19.37% |
2018 | $0.98 | 98.42% |
2017 | $0.50 | 41.84% |
2016 | $0.35 | 1227.12% |
2015 | $0.02631 | -117.81% |
2014 | -$0.15 | 184.25% |
2013 | -$0.05198 | -12.81% |
2012 | -$0.05962 | -433.93% |
2011 | $0.01785 | -126.14% |
2010 | -$0.06829 | -258.4% |
2009 | $0.04311 |